The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study
Open accessAbstract
Objective: To evaluate the association between use of hormone replacement therapy and the risk of idiopathic venous thromboembolism. Design: Population based case-control study. Setting: Population enrolled in the General Practice Research Database, United Kingdom. Subjects: A cohort of 347 253 women aged 50 to 79 without major risk factors for venous thromboembolism was identified. Cases were 292 women admitted to hospital for a first episode of pulmonary embolism or deep venous thrombosis; 10 000 controls were randomly selected from the source cohort. Main outcome measures: Adjusted relative risks estimated from unconditional logistic regression. Results: The adjusted odds ratio of venous thromboembolism for current use of hormone replacement therapy compared with non-users was 2.1 (95% confidence interval 1.4 to 3.2). This increased risk was restricted to first year users, with odds ratios of 4.6 (2.5 to 8.4) during the first six months and 3.0 (1.4 to 6.5) 6-12 months after starting treatment. No major risk differences were observed between users of low and high doses of oestrogens, unopposed and opposed treatment, and oral and transdermal preparations. The risk of idiopathic venous thromboembolism among non-users of replacement therapy was estimated to be 1.3 per 10 000 women per year. Among current users, idiopathic venous thromboembolism occurs at two to three times the rate in non-users, resulting in one to two additional cases per 10 000 women per year. Conclusions: Current use of hormone replacement therapy was associated with a higher risk of venous thromboembolism, although the risk seemed to be restricted to the first year of use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Risk of venous thromboembolism in users of hormone replacement therapy
Daly, E., Vessey, M. P., Hawkins, M. M., Carson, J. L., Gough, P., & Marsh, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07113-9 · Cited by 819
Jick, H., Derby, L. E., Myers, M. W., Vasilakis, C., & Newton, K. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07114-0 · Cited by 602
Prospective study of exogenous hormones and risk of pulmonary embolism in women
Grodstein, F., Stampfer, M. J., Goldhaber, S. Z., Manson, J. E., Colditz, G. A., Speizer, F. E., Willett, W. C., & Hennekens, C. H. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07308-4 · Cited by 571
Prior to Use of Estrogen Replacement Therapy, Are Users Healthier than Nonusers?
Matthews, K. A., Kuller, L. H., Wing, R. R., Meilahn, E. N., & Plantinga, P. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008678 · Cited by 517
NACHTIGALL, L. E., NACHTIGALL, R. H., NACHTIGALL, R. D., & BECKMAN, M. E. (1979) · Obstetrics & Gynecology · doi:10.1097/00006250-197907000-00017 · Cited by 446
Effects of long-term estrogen replacement therapy
Hammond, C. B., Jelovsek, F. R., Lee, K. L., Creasman, W. T., & Parker, R. T. (1979) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(79)90288-6 · Cited by 370
the Boston Collaborative Drug Surveillance Program, B. U. M. C. (1974) · New England Journal of Medicine · doi:10.1056/nejm197401032900104 · Cited by 345
Jick, H., Terris, B. Z., Derby, L. E., & Jick, S. S. (1992) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630010607 · Cited by 265
EVIDENCE OF A HEALTHY ESTROGEN USER SURVIVOR EFFECT
Sturgeon, S. R., Schairer, C., Brinton, L. A., Pearson, T., & Hoover, R. N. (1995) · Epidemiology · doi:10.1097/00001648-199505000-00006 · Cited by 188
Estrogen replacement therapy and the risk of venous thrombosis
Devor, M., Barrett-Connor, E., Renvall, M., Feigal, D., & Ramsdell, J. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90077-o · Cited by 177
Potshuma, W. F. M., Westendorp, R. G. J., & Vandenbroucke, J. P. (1994) · BMJ · doi:10.1136/bmj.308.6939.1268 · Cited by 162
Petitti, D. B. (1979) · JAMA · doi:10.1001/jama.1979.03300110022020 · Cited by 158
Grodstein, F. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008679 · Cited by 60
Fieguth, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-63168-0_11 · Cited by 8
Estrogen Replacement Therapy and the Risk of Venous Thrombosis
Devor, M., Barrett-Connor, E. L., & Renvall, M. J. (1992) · The Endocrinologist · doi:10.1097/00019616-199207000-00019 · Cited by 4
Cited by
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,930
Postmenopausal Hormone Replacement Therapy: Scientific Review
Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., & Allan, J. D. (2002) · JAMA · doi:10.1001/jama.288.7.872 · Cited by 990
Metadata
- Authors
- Gutthann, S. P., Rodriguez, L. A. G., Castellsague, J., & Oliart, A. D.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1997-03-15
- Volume
- 314
- Issue
- 7083
- Pages
- 796
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2021062942
- Cited by
- 338
- References
- 16
- FWCI
- 18.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.